Stocktoria

Senti Biosciences Holdings, Inc. SNTI

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-05-26

Senti Biosciences Holdings, Inc. statistics & valuation

Market cap$33.9M
P / B6.1×
Net margin-279263.6%
FCF margin-198363.6%
Return on capital-184.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-2003.60% -1358.10% -2774.60% -279263.60% 20212022202320242025
Gross margin (%)
20212022202320242025
Operating margin (%)
-1464.90% -1448.50% -3620.70% -312631.80% 20212022202320242025
Return on equity (%)
-45.70% -106.20% -205.80% -1099.30% 20212022202320242025
Shares outstanding
3.0M 44.1M 4.6M 4.8M 30.9M 20212022202320242025
Net debt ($)
20212022202320242025
Share buybacks ($)
20212022202320242025
Return on assets (%)
-57.20% -32.20% -59.50% -54.00% -119.90% 20212022202320242025
Free cash flow margin (%)
-1455.20% -1779.50% -2515.90% -198363.60% 20212022202320242025
Debt / equity (×)
20212022202320242025
EPS ($)
-$19.00 -$2.23 -$16.01 -$12.03 -$2.73 20212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021
Operating margin-312631.8%—-3620.7%-1448.5%-1464.9%
Net margin-279263.6%—-2774.6%-1358.1%-2003.6%
FCF margin-198363.6%—-2515.9%-1779.5%-1455.2%
Return on assets-119.9%-54.0%-59.5%-32.2%-57.2%
Return on equity-1099.3%-205.8%-106.2%-45.7%49.6%
Current ratio1.674.495.625.684.14

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.